Page last updated: 2024-10-30
metformin and Dengue Hemorrhagic Fever
metformin has been researched along with Dengue Hemorrhagic Fever in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Research Excerpts
Excerpt | Relevance | Reference |
"Diabetes mellitus is a risk factor for severe dengue in adults, but few studies have examined the association between metformin use and disease severity in dengue." | 7.88 | Metformin Use and Severe Dengue in Diabetic Adults. ( Htun, HL; Leo, YS; Lye, DC; Pang, J; Tam, CC; Yeo, TW, 2018) |
"Diabetes mellitus is a risk factor for severe dengue in adults, but few studies have examined the association between metformin use and disease severity in dengue." | 3.88 | Metformin Use and Severe Dengue in Diabetic Adults. ( Htun, HL; Leo, YS; Lye, DC; Pang, J; Tam, CC; Yeo, TW, 2018) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
Htun, HL | 1 |
Yeo, TW | 1 |
Tam, CC | 1 |
Pang, J | 1 |
Leo, YS | 1 |
Lye, DC | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Metformin as Adjunctive Therapy in Overweight and Obese Patients With Dengue: an Open-label Safety and Tolerability Trial[NCT04377451] | Phase 1/Phase 2 | 120 participants (Actual) | Interventional | 2020-07-27 | Completed |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for metformin and Dengue Hemorrhagic Fever